BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22554173)

  • 21. Prediction of endometrial malignancy in women with postmenopausal bleeding and sonographic endometrial thickness ≥ 4.5 mm.
    Opolskiene G; Sladkevicius P; Valentin L
    Ultrasound Obstet Gynecol; 2011 Feb; 37(2):232-40. PubMed ID: 21061264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of postmenopausal women with vaginal bleeding when the endometrium can not be visualized.
    Burbos N; Musonda P; Crocker SG; Morris EP; Nieto JJ; Duncan TJ
    Acta Obstet Gynecol Scand; 2012 Jun; 91(6):686-91. PubMed ID: 22443120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postmenopausal bleeding-first steps in the workup.
    Null DB; Weiland CM; Camlibel AR
    J Fam Pract; 2012 Oct; 61(10):597-604. PubMed ID: 23106061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic utility of three-dimensional power Doppler ultrasound for postmenopausal bleeding.
    Kim A; Lee JY; Chun S; Kim HY
    Taiwan J Obstet Gynecol; 2015 Jun; 54(3):221-6. PubMed ID: 26166330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of investigations for postmenopausal vaginal bleeding in women under the age of 50 years.
    Burbos N; Musonda P; Crocker SG; Morris EP; Duncan TJ; Nieto JJ
    Gynecol Oncol; 2012 Apr; 125(1):120-3. PubMed ID: 22233690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Guideline for the diagnosis of postmenopausal bleeding. PMPB Working Group of the SGGG].
    Bronz L; Dreher E; Almendral A; Studer A; Haller U
    Gynakol Geburtshilfliche Rundsch; 2000; 40(2):71-9. PubMed ID: 10971089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective validation of two mathematical models to calculate the risk of endometrial malignancy in patients with postmenopausal bleeding and sonographic endometrial thickness ≥4.5 mm.
    Sladkevicius P; Valentin L
    Eur J Cancer; 2016 May; 59():179-188. PubMed ID: 27043175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The contribution of hysteroscopy to the detection malignancy in symptomatic postmenopausal women.
    Liberis V; Tsikouras P; Christos Z; Ammari A; Dislian V; Koutlaki N; Liberis A; Maroulis G
    Minim Invasive Ther Allied Technol; 2010 Apr; 19(2):83-93. PubMed ID: 20158408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective temporal validation of mathematical models to calculate risk of endometrial malignancy in patients with postmenopausal bleeding.
    Sladkevicius P; Opolskiene G; Valentin L
    Ultrasound Obstet Gynecol; 2017 May; 49(5):649-656. PubMed ID: 27072497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of transvaginal sonography in detecting endometrial pathologies in postmenopausal women with or without bleeding.
    Ates S; Sevket O; Sudolmus S; Ozel A; Molla T; Dane B; Dansuk R
    Minerva Ginecol; 2014 Aug; 66(4):335-40. PubMed ID: 25020052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endometrial pathology in postmenopausal women with no bleeding.
    Genc M; Genc B; Sahin N; Celik E; Turan GA; Gur EB; Guclu S
    Climacteric; 2015 Apr; 18(2):241-5. PubMed ID: 25017611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endometrial SamPling befoRe or aftEr Saline infusion SOnography (ESPRESSO Trial): a national survey and a study protocol of a multicenter RCT.
    Vroom AJ; Prins MM; Bongers MY; Geomini PM; Timmermans A; Hanegem NV
    Minerva Ginecol; 2017 Jun; 69(3):304-308. PubMed ID: 28252269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of cervical cytology in diagnosing endometrial carcinoma in women with postmenopausal bleeding.
    van Doom HC; Opmeer BC; Kooi GS; Ewing-Graham PC; Kruitwagen RF; Mol BW
    Acta Cytol; 2009; 53(3):277-82. PubMed ID: 19534267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managing postmenopausal bleeding revisited: what is the best first line investigation and who should be seen within 2 weeks? A cross-sectional study of 326 women.
    Ewies AA; Musonda P
    Eur J Obstet Gynecol Reprod Biol; 2010 Nov; 153(1):67-71. PubMed ID: 20650562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost analysis model: US versus endometrial biopsy in evaluation of peri- and postmenopausal abnormal vaginal bleeding.
    Medverd JR; Dubinsky TJ
    Radiology; 2002 Mar; 222(3):619-27. PubMed ID: 11867775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controversies on Transvaginal Ultrasound Screening for Endometrial Cancer in Asymptomatic Postmenopausal Women.
    Tsikouras P; Bacha M; Zervoudis S; Koukouli Z; Iatrakis G; Galazios G; Maroulis G; Virtej I; Onofriescu M
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(4):855-60. PubMed ID: 30141611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis of endometrial cancer in patients with postmenopausal bleeding by analysis of the lactate dehydrogenase isoenzyme activity profile in uterine fluid.
    Niklasson O; Skude G; Marsal K; Casslén B
    Gynecol Oncol; 2004 May; 93(2):385-9. PubMed ID: 15099950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-dimensional power Doppler ultrasound scanning for the prediction of endometrial cancer in women with postmenopausal bleeding and thickened endometrium.
    Alcazar JL; Galvan R
    Am J Obstet Gynecol; 2009 Jan; 200(1):44.e1-6. PubMed ID: 18976731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing the performance of two clinical models in estimating the risk of endometrial cancer in symptomatic postmenopausal women.
    Musonda P; Burbos N; Duncan TJ; Crocker SG; Morris EP; Nieto JJ
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):433-8. PubMed ID: 21975177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-dimensional power Doppler and endometrial volume as predictors of malignancy in patients with postmenopausal bleeding.
    Makled AK; Elmekkawi SF; El-Refaie TA; El-Sherbiny MA
    J Obstet Gynaecol Res; 2013 May; 39(5):1045-51. PubMed ID: 23379512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.